1.
|
Johnson,
M. Interactions between Corticosteroids and β2-Agonists in Asthma and Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 2004; 1: 200- 206. |
2. |
Global
Initiative for Asthma (GINA) guidelines, 2005 up-date. |
3. |
Rhen,
T. and Cidlowski, J. A. Antiinflammatory Actions
of Glucocorticoids-New Mechanisms for old Drugs. NEJM 2005; 353: 1711-1723. |
4. |
Barnes,
P. J. Molecular Mechanisms and Cellular effects
of Glucocorticosteroids. Immunol Allergy Clin N Am 2005; 25: 451-468. |
5. |
Barnes,
P. J. and Stockley, R. A. COPD: current therapeutic
interventions and future approaches. Eur Respir J 2005; 25: 1084-1106. |
6. |
Johnson,
M. Molecular mechanisms of β2-adrenergic receptor function, response, and regulation. J Allergy Clin Immunol 2006; 117: 18-24. |
7. |
Barnes,
P. J. Scientific rationale for inhaled combination
therapy with long-acting β2-agonists and corticosteroids. Eur Respir J 2002; 19: 182-191. |
8. |
Hansel,
T. T. and Barnes, P. J. An Atlas of Chronic Obstructive
Pulmonary Disease-COPD. 2004. |
9. |
Mak,
J.C. Glucocorticosteroids increase β2-adrenergic receptor transcription in human lung. Am J Physiol 1995; 12: L41-L46. |
10. |
Mak,
J.C. Protective effects of a glucocorticoid on
down-regulation of pulmonary β2-adrenergic receptors
in vivo. J Clin Invest 1995; 96: 99-106. |
11. |
Baraniuk,
J.N. Glucocorticoids induce β2-adrenergic receptor function in human nasal mucosa. Am J Respir Crit Care Med 1997; 155: 704-710. |
12. |
Chong,
L.K. Beta-adrenoceptor reserve in human lung: a
comparison between airway smooth muscle and mast
cells. Eur J Pharmacol 1999; 378: 115-122. |
13. |
Adcock,
I.M. Effects of LABA on GR function: possible role
of GR phosphorylation. J Allergy Clin Immunol 2002; 110: S261-S268. |
14. |
Eickelberg,
O. Ligand-independent activation of the glucocorticoid
receptor by β2-adrenergic receptor agonists in primary human lung fibroblasts and vascular
smooth muscle cells. J Biol Chem 1999; 274: 1005-1010. |
15. |
Usmani,
O.S. Glucocorticoid receptor activation following
inhaled fluticasone and salmeterol. Am J Resp Crit Care Med 2002; 165: A618. |
16. |
Profita,
M. Biochemical interaction between effects of beclomethasone
dipropionate and salbutamol or formoterol in sputum
cells from mild to moderate asthmatics. Allergy 2005: 60: 323–329. |
17. |
Barnes,
N.C. Anti-inflammatory Effects of Salmeterol/Fluticasone
Propionate in Chronic Obstructive Disease. Am J Respir Crit Care Med. 2006; 173: 736-743. |
18. |
Pauwels,
R. A. et al., N Engl J Med 1997; 1405-1411. |
19. |
Zetterström,
O. et al., Eur Respir J 2001; 18: 262-268. |
20. |
Umesh,
G. et al., Chest 2003; 1480-1487. |
21. |
Calverley,
P. M. et al., Eur Respir J 2003; 22: 912-919. |
22. |
Szafranski,
W. et al., Eur Respir J 2003; 21: 74-81. |
23. |
Mahler,
D. A. et al., Am J Respir Crit Care Med 2002; 166: 1084-1091. |
24. |
Hanania,
N. A. et al., Chest 2003; 124: 834-843. |
25. |
Calverley,
P. M. et al., The Lancet 2003; 361: 449-456. |
26 |
Calverley P.M. et al, N Engl J Med 2007; 356 : 775-789 |